Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB11714 | Durvalumab | 1 / 2 | Terminated | 1 |
DB11771 | Tremelimumab | 1 / 2 | Terminated | 1 |
DB00958 | Carboplatin | 2 | Recruiting | 1 |
DB00515 | Cisplatin | 2 | Recruiting | 1 |
DB06186 | Ipilimumab | 2 | Recruiting | 1 |
DB09035 | Nivolumab | 2 | Recruiting | 1 |
DB01229 | Paclitaxel | 2 | Recruiting | 1 |
DB14547 | Chloride ion | 2 / 3 | Suspended | 1 |
DB00515 | Cisplatin | 2 / 3 | Suspended | 1 |
DB09035 | Nivolumab | 2 / 3 | Suspended | 1 |
DB12257 | Platinum | 2 / 3 | Suspended | 1 |
DB14547 | Chloride ion | 3 | Recruiting | 1 |
DB00515 | Cisplatin | 3 | Recruiting | 1 |
DB09035 | Nivolumab | 3 | Recruiting | 1 |
DB12257 | Platinum | 3 | Recruiting | 1 |